About Me
Conditions and Treatments
Conditions
- diabetic retinopathy
- uveitis
Treatments
- laser surgery
- retinal surgery
- vitrectomy
Credentials
Positions
- Clinical Professor, Department of Ophthalmology at NYU Grossman School of Medicine
Board Certifications
- American Board of Ophthalmology - Ophthalmology, 1991
Education and Training
- Fellowship, Washington University Medical Center, Vitreoretinal Surgery, 1991
- Residency, NYU Medical Center, Ophthalmology, 1989
- Fellowship, University of Illinois Hospital and Clinics, Retina, 1986
- MD from SUNY-Downstate, 1984
Is this your profile?
Edit profileInsurance Plans Accepted
This provider accepts the following insurance plans.
-
Aetna
- Aetna HMO
- Aetna Indemnity
- Aetna Medicare
- Aetna POS
- Aetna PPO/EPO
-
Blue Cross Blue Shield
- Empire BCBS Top Tier
-
Empire Blue Cross Blue Shield
- Empire Blue Cross Blue Shield EPO
- Empire Blue Cross Blue Shield HMO
- Empire Blue Cross Blue Shield Indemnity
- Empire Blue Cross Blue Shield MediBlue
- Empire Blue Cross Blue Shield POS
- Empire Blue Cross Blue Shield PPO
- Empire Blue Cross Blue Shield Pathways, Enhanced
-
Oxford
- Oxford Freedom
-
UHC
- UnitedHealthcare EPO
- UnitedHealthcare HMO
- UnitedHealthcare POS
- UnitedHealthcare PPO
- UnitedHealthcare Top Tier
Carol M. Lee, MD does not accept insurance.
Locations and Appointments
Carol M. Lee, M.D.
161 Madison Ave, Ste 5NE, New York, NY 10016
Carol M. Lee, M.D.
530 1st Ave, Ste 3B, New York, NY 10016
Clinical Trials and Research Studies
-
Learn More
A Phase 1b Trial of ZEN003694 (ZEN-3694) with Pembrolizumab and Nab-Paclitaxel in Patients with Metastatic Triple-Negative Breast Cancer
-
Learn More
A Randomised Open-Label Phase III Study of Saruparib (AZD5305) Plus Camizestrant compared with Physician's Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of Patients With BRCA1 BRCA2 or PALB2 Mutations and Hormone Receptor Positive HER2-Negative (IHC 0 1+ 2+/ ISH non-amplified) Advanced Breast Cancer (EvoPAR-Breast01)
-
Learn More
A Phase 1b Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Publications
-
Neeki, Michael; Dong, Fanglong; Lowe, Lydia; Cerda, Melinda; Peace, Carlos; Roloff, Kristina; Lee, Carol
Cureus. 2020 Jun 04; 12(6):e8446
-
Gupta, Akash; Tsui, Edmund; Sarrafpour, Soshian; Lee, Carol M; Modi, Yasha S
Ocular immunology & inflammation. 2018 Jul 03; 1-4
-
Lee, Caroline; Ramsey, Austin; De Brito-Gariepy, Helaine; Michot, Benoit; Podborits, Eugene; Melnyk, Janet; Gibbs, Jennifer Lynn Gibbs
Molecular pain. 2017 Jan-Dec; 13:1744806917715173